US Broker Ratings

Glaukos Corporation (GKOS) Stock Analysis: Assessing Growth Potential Amid a Robust Revenue Surge

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its significant market presence and promising growth trajectory...

CVS Health Corporation (CVS) Stock Analysis: Navigating a 19.47% Potential Upside with Robust Revenue Growth

CVS Health Corporation (NYSE: CVS), a heavyweight in the healthcare sector, is capturing investor attention with a compelling proposition of a 19.47% potential upside according to recent analyst ratings. With..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Glimpse into the 14.86% Potential Upside

Investors keeping an eye on the healthcare sector might want to delve deeper into Jazz Pharmaceuticals plc (NASDAQ: JAZZ). With a market capitalization of $15.9 billion, this Dublin-based biotech entity..

Nuvalent, Inc. (NUVL) Stock Analysis: Steady at $123.96 with Phase 2 Clinical Trials on the Horizon

For investors focused on the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a unique profile as a clinical-stage biopharmaceutical company targeting breakthrough therapies for cancer patients. With a market capitalization..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Growth Amidst Healthcare Industry Volatility

Avantor, Inc. (NYSE: AVTR) stands as a significant player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $9.24 billion, Avantor is..

DexCom, Inc. (DXCM): Investor Outlook on a Leading Medical Device Innovator with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM) stands out in the healthcare sector as a prominent player in the medical devices industry, specializing in continuous glucose monitoring (CGM) systems. Headquartered in San Diego,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating the 11.34% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, commanding attention with its robust market cap of $128.19 billion. Operating at the intersection of healthcare..

Biogen Inc. (BIIB) Investor Outlook: Exploring a Promising 13.23% Potential Upside

Biogen Inc. (BIIB), a stalwart in the healthcare sector, has long been recognized for its innovative therapies and robust pipeline in the drug manufacturing industry. With a market capitalization of..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring Growth Potential with RAS-Targeted Therapies

Revolution Medicines, Inc. (NASDAQ: RVMD), a prominent player in the biotechnology sector, is drawing significant attention from investors with its cutting-edge approach to precision oncology. Headquartered in Redwood City, California,..

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) continues to capture the attention of investors with its diverse portfolio of over-the-counter (OTC) healthcare and personal care products. Headquartered in Tarrytown, New York,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with Innovative Diagnostics

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the medical devices industry, stands at the forefront of healthcare innovation, offering a wide array of life science research and clinical..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Assessing the 12.59% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a global leader in the healthcare sector, continues to capture the attention of investors with its diverse portfolio and strategic positioning in the specialty..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Biotech Powerhouse with 33.59% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is gaining attention in the biotech sector, primarily due to its innovative approach to treating metabolic dysfunction-associated steatohepatitis (MASH). With a current market capitalization of..

Centene Corporation (CNC) Stock Analysis: Evaluating the 6.22% Potential Upside Amidst Healthcare Industry Dynamics

Centene Corporation (NYSE: CNC), a major player in the healthcare plans industry, is making waves in the investment community with a potential upside of 6.22% according to current analyst ratings...

Teleflex Incorporated (TFX) Stock Report: Analyzing a 11.21% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors. With a market capitalization of $5.81 billion,..

Ascendis Pharma A/S (ASND) Stock Analysis: Healthcare Innovator with a 25% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical company, is making significant waves in the biotechnology sector with its innovative TransCon-based therapies. With a robust market capitalization of $16.3 billion,..

Option Care Health, Inc. (OPCH) Stock Analysis: Navigating Growth with a 19% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector as a prominent provider of home and alternate site infusion services across the United States. With a market..

Charles River Laboratories (CRL) Stock Analysis: Navigating an Evolving Landscape with a $13.49 Billion Market Cap

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, operating within the diagnostics and research industry. With a robust market capitalization of $13.49..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Its Growth Potential and Strategic Position in Diagnostics

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, is carving out a significant niche in the diagnostics and research industry. Based in Venlo, Netherlands, Qiagen specializes in transforming..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds